EMaBS TB Vaccine Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 72
Summary
- Conditions
- Immunogenicity
- Safety
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Masking Description: This will be an open label trial as it will not be possible to blind either volunteers or clinic staff to the allocation. However, laboratory staff will be blinded to the allocation of the volunteers as they undertake the immunological assays.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 12 years and 49 years
- Gender
- Both males and females
Description
This trial will be financed by a research grant from Medical Research Council. The reference number of the grant held by MRC-UKRI is MC_UU_00027/5.
This trial will be financed by a research grant from Medical Research Council. The reference number of the grant held by MRC-UKRI is MC_UU_00027/5.
Tracking Information
- NCT #
- NCT03681860
- Collaborators
- MRC/UVRI and LSHTM Uganda Research Unit
- Investigators
- Principal Investigator: Helen McShane, Professor University of Oxford